Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-26-000009

CEO sold 5,394 shares at $2.02 ($10,894)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Sale : show line 1 in the form 10b5-1 −5,394 $2.02 $10,894 263,693 D
Open-market sales · 5,394 sh · avg $2.02 · $10,894
Loading xslF345X05/wk-form4_1772661358.xml…